Moderation of the relationship between Toxoplasma gondii seropositivity and trait impulsivity in younger men by the phenylalanine-tyrosine ratio

Psychiatry Research

Volumn 270, Issue , 2018, Pages 992-1000

  Peng, Xiaoqing ^a,b   Brenner, Lisa A ^c,d,e   Mathai, Ashwin J ^a,b   Cook, Thomas B ^f   Fuchs, Dietmar ^g   Postolache, Nadine ^a   Groer, Maureen W ^h   Pandey, Janardan P ⁱ   Mohyuddin, Farooq ^b   Giegling, Ina ^j   Wadhawan, Abhishek ^a,b   Hartmann, Annette M ^j   Konte, Bettina ^j   Brundin, Lena ^k   Friedl, Marion ^j   Stiller, John W ^a,b   Lowry, Christopher A ^c,d,e,l   Rujescu, Dan ^j   Postolache, Teodor T ^a,c,e,m  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b St Elizabeths Hospital   (United States)

^c Education and Clinical Center (MIRECC)   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Military and Veteran Microbiome Consortium of Research and Education (MVM CORE)   (United States)

^f MERCYHURST COLLEGE   (United States)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^k VAN ANDEL RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF COLORADO   (United States)

^m VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Dopamine precursor; Impulsivity; Kynurenine; Phenylalanine; Serotonin precursor; Toxoplasma gondii; Tryptophan; Tyrosine

Indexed keywords

DOPAMINE; KYNURENINE; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SEROLOGY; SEX DIFFERENCE; TOXOPLASMA GONDII; AGED; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMANY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PSYCHOLOGY; SEROEPIDEMIOLOGY; SEX FACTOR; TOXOPLASMA; TOXOPLASMOSIS;

ADULT; AGE FACTORS; AGED; ANTIBODIES, PROTOZOAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HEALTHY VOLUNTEERS; HUMANS; IMMUNOGLOBULIN G; IMPULSIVE BEHAVIOR; KYNURENINE; MALE; MIDDLE AGED; PHENYLALANINE; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; SEX FACTORS; TOXOPLASMA; TOXOPLASMOSIS; TRYPTOPHAN; TYROSINE;

EID: 85050391059     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2018.03.045     Document Type: Article

References (161)

1. Abdollahian, E., Shafiei, R., Mokhber, N., Kalantar, K., Fata, A., Seroepidemiological study of Toxoplasma gondii infection among psychiatric patients in Mashhad, Northeast of Iran. Iran. J. Parasitol. 12:1 (2017), 117–122.
2. Allen, T.J., Moeller, F.G., Rhoades, H.M., Cherek, D.R., Impulsivity and history of drug dependence. Drug Alcohol Depend. 50:2 (1998), 137–145.
3. Alvarado-Esquivel, C., Sanchez-Anguiano, L.F., Arnaud-Gil, C.A., Lopez-Longoria, J.C., Molina-Espinoza, L.F., Estrada-Martinez, S., et al. Toxoplasma gondii infection and suicide attempts: a case-control study in psychiatric outpatients. J. Nerv. Ment. Dis. 201:11 (2013), 948–952.
4. Anderson, D.N., Wilkinson, A.M., Abou-Saleh, M.T., Blair, J.A., Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation. Acta Psychiatr. Scand. 90:1 (1994), 10–13.
5. Ansari-Lari, M., Farashbandi, H., Mohammadi, F., Association of Toxoplasma gondii infection with schizophrenia and its relationship with suicide attempts in these patients. Trop. Med. Int. Health 22:10 (2017), 1322–1327.
6. Arling, T.A., Yolken, R.H., Lapidus, M., Langenberg, P., Dickerson, F.B., Zimmerman, S.A., et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J. Nerv. Ment. Dis. 197:12 (2009), 905–908.
7. Ballester, J., Goldstein, T., Goldstein, B., Obreja, M., Axelson, D., Monk, K., et al. Is bipolar disorder specifically associated with aggression?. Bipolar Disord. 14:3 (2012), 283–290.
8. Bay-Richter, C., Linderholm, K.R., Lim, C.K., Samuelsson, M., Traskman-Bendz, L., Guillemin, G.J., et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav. Immun. 43 (2015), 110–117.
9. Bechara, A., Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 8:11 (2005), 1458–1463.
10. Berenreiterova, M., Flegr, J., Kubena, A.A., Nemec, P., The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS One, 6(12), 2011, e28925.
11. Besson, M., Belin, D., McNamara, R., Theobald, D.E., Castel, A., Beckett, V.L., et al. Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. Neuropsychopharmacology 35:2 (2010), 560–569.
12. Besson, M., Pelloux, Y., Dilleen, R., Theobald, D.E., Lyon, A., Belin-Rauscent, A., et al. Cocaine modulation of frontostriatal expression of Zif268, D2, and 5-HT2c receptors in high and low impulsive rats. Neuropsychopharmacology 38:10 (2013), 1963–1973.
13. Bhatt, S., Bhatt, R., Zalcman, S.S., Siegel, A., Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat. Brain Behav. Immun. 22:2 (2008), 224–233.
14. Bortolato, M., Shih, J.C., Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int. Rev. Neurobiol. 100 (2011), 13–42.
15. Brady, K.T., Myrick, H., McElroy, S., The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am. J. Addict. 7:3 (1998), 221–230.
16. Brietzke, E., Stabellini, R., Grassi-Oliveira, R., Lafer, B., Cytokines in bipolar disorder: recent findings, deleterious effects but promise for future therapeutics. CNS Spectr. 16:7 (2011), 157–168.
17. Brundin, L., Erhardt, S., Bryleva, E.Y., Achtyes, E.D., Postolache, T.T., The role of inflammation in suicidal behaviour. Acta Psychiatr. Scand. 132:3 (2015), 192–203.
18. Capuron, L., Schroecksnadel, S., Feart, C., Aubert, A., Higueret, D., Barberger-Gateau, P., et al. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol. Psychiatry 70:2 (2011), 175–182.
19. Chester, D.S., DeWall, C.N., Derefinko, K.J., Estus, S., Lynam, D.R., Peters, J.R., et al. Looking for reward in all the wrong places: dopamine receptor gene polymorphisms indirectly affect aggression through sensation-seeking. Soc. Neurosci. 11:5 (2016), 487–494.
20. Coccaro, E.F., Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J. Psychiatr. Res. 40:5 (2006), 460–465.
21. Coccaro, E.F., Lee, R., Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J. Neural Transm. (Vienna) 117:2 (2010), 241–248.
22. Coccaro, E.F., Lee, R., Coussons-Read, M., Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry 71:2 (2014), 158–165.
23. Coccaro, E.F., Lee, R., Groer, M.W., Can, A., Coussons-Read, M., Postolache, T.T., Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J. Clin. Psychiatry 77:3 (2016), 334–341.
24. Cole, B.J., Robbins, T.W., Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav. Brain Res. 33:2 (1989), 165–179.
25. Constantinou, E., Panayiotou, G., Konstantinou, N., Loutsiou-Ladd, A., Kapardis, A., Risky and aggressive driving in young adults: personality matters. Accid. Anal. Prev. 43:4 (2011), 1323–1331.
26. Cook, T.B., Brenner, L.A., Cloninger, C.R., Langenberg, P., Igbide, A., Giegling, I., et al. “Latent” infection with Toxoplasma gondii: association with trait aggression and impulsivity in healthy adults. J. Psychiatr. Res. 60 (2015), 87–94.
27. Costa, A., la Fougere, C., Pogarell, O., Moller, H.J., Riedel, M., Ettinger, U., Impulsivity is related to striatal dopamine transporter availability in healthy males. Psychiatry Res. 211:3 (2013), 251–256.
28. Cotter, D.R., Pariante, C.M., Everall, I.P., Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 55:5 (2001), 585–595.
29. Czapla, M., Simon, J.J., Richter, B., Kluge, M., Friederich, H.C., Herpertz, S., et al. The impact of cognitive impairment and impulsivity on relapse of alcohol-dependent patients: implications for psychotherapeutic treatment. Addict. Biol, 2015.
30. Dalley, J.W., Fryer, T.D., Brichard, L., Robinson, E.S., Theobald, D.E., Laane, K., et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:5816 (2007), 1267–1270.
31. Dalley, J.W., Roiser, J.P., Dopamine, serotonin and impulsivity. Neuroscience 215 (2012), 42–58.
32. Daubner, S.C., Le, T., Wang, S., Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem. Biophys. 508:1 (2011), 1–12.
33. de Witte, L., Tomasik, J., Schwarz, E., Guest, P.C., Rahmoune, H., Kahn, R.S., et al. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr. Res. 154:1–3 (2014), 23–29.
34. Del Grande, C., Galli, L., Schiavi, E., Dell'Osso, L., Bruschi, F., Is Toxoplasma gondii a trigger of bipolar disorder?. Pathogens, 6(1), 2017.
35. Di Cristina, M., Marocco, D., Galizi, R., Proietti, C., Spaccapelo, R., Crisanti, A., Temporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivo. Infect. Immun. 76:8 (2008), 3491–3501.
36. Dickerson, F., Wilcox, H.C., Adamos, M., Katsafanas, E., Khushalani, S., Origoni, A., et al. Suicide attempts and markers of immune response in individuals with serious mental illness. J. Psychiatr. Res. 87 (2017), 37–43.
37. Djamshidian, A., O'Sullivan, S.S., Foltynie, T., Aviles-Olmos, I., Limousin, P., Noyce, A., et al. Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease. J. Parkinsons Dis. 3:2 (2013), 139–144.
38. Dolan, M., Anderson, I.M., Deakin, J.F., Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br. J. Psychiatry 178 (2001), 352–359.
39. Dupont, C.D., Christian, D.A., Hunter, C.A., Immune response and immunopathology during toxoplasmosis. Semin. Immunopathol. 34:6 (2012), 793–813.
40. Eagle, D.M., Wong, J.C., Allan, M.E., Mar, A.C., Theobald, D.E., Robbins, T.W., Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J. Neurosci. 31:20 (2011), 7349–7356.
41. Ebstein, R.P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet. 12:1 (1996), 78–80.
42. Elsheikha, H.M., Zhu, X.Q., Toxoplasma gondii infection and schizophrenia: an inter-kingdom communication perspective. Curr. Opin. Infect. Dis. 29:3 (2016), 311–318.
43. Fernando, A.B., Economidou, D., Theobald, D.E., Zou, M.F., Newman, A.H., Spoelder, M., et al. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology (Berl) 219:2 (2012), 341–352.
44. First MB, S., Robert L., Gibbon Miriam, and Williams, Janet B.W, 2002. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P).
45. Flegr, J., Effects of toxoplasma on human behavior. Schizophr. Bull. 33:3 (2007), 757–760.
46. Flegr, J., Havlicek, J., Kodym, P., Maly, M., Smahel, Z., Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis., 2, 2002, 11.
47. Flegr, J., Kodym, P., Tolarova, V., Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol. Psychol. 53:1 (2000), 57–68.
48. Flegr, J., Lindova, J., Kodym, P., Sex-dependent toxoplasmosis-associated differences in testosterone concentration in humans. Parasitology 135:4 (2008), 427–431.
49. Flegr, J., Zitkova, S., Kodym, P., Frynta, D., Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 113:Pt 1 (1996), 49–54.
50. Fond, G., Capdevielle, D., Macgregor, A., Attal, J., Larue, A., Brittner, M., Ducasse, D., Boulenger, J.P., Toxoplasma gondii: a potential role in the genesis of psychiatric disorders. Encephale 39:1 (2013), 38–43.
51. Fujigaki, S., Saito, K., Takemura, M., Maekawa, N., Yamada, Y., Wada, H., et al. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect. Immun. 70:2 (2002), 779–786.
52. Fuglewicz, A.J., Piotrowski, P., Stodolak, A., Relationship between toxoplasmosis and schizophrenia: A review. Adv. Clin. Exp. Med. 26:6 (2017), 1031–1036.
53. Gaskell, E.A., Smith, J.E., Pinney, J.W., Westhead, D.R., McConkey, G.A., A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One, 4(3), 2009, e4801.
54. Georgiou, P., Zanos, P., Bhat, S., Tracy, J.K., Merchenthaler, I.J., McCarthy, M.M., Gould, T.D., Dopamine and Stress System Modulation of Sex Differences in Decision Making. Neuropsychopharmacol. 43:2 (2018), 313–324, 10.1038/npp.2017.161 Epub 2017 Jul 25. PubMed PMID: 28741626; PubMed Central PMCID: PMC5729565.
55. Ghahremani, D.G., Lee, B., Robertson, C.L., Tabibnia, G., Morgan, A.T., De Shetler, N., et al. Striatal dopamine D(2)/D(3) receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J. Neurosci. 32:21 (2012), 7316–7324.
56. Graham, J.E., Robles, T.F., Kiecolt-Glaser, J.K., Malarkey, W.B., Bissell, M.G., Glaser, R., Hostility and pain are related to inflammation in older adults. Brain Behav. Immun. 20:4 (2006), 389–400.
57. Hamilton, K.R., Mitchell, M.R., Wing, V.C., Balodis, I.M., Bickel, W.K., Fillmore, M., et al. Choice impulsivity: definitions, measurement issues, and clinical implications. Personal Disord. 6:2 (2015), 182–198.
58. Haroon, E., Raison, C.L., Miller, A.H., Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:1 (2012), 137–162.
59. Hinze-Selch, D., Daubener, W., Erdag, S., Wilms, S., The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol. (Praha) 57:2 (2010), 129–135.
60. Hoekstra, R., van den Broek, W.W., Fekkes, D., Bruijn, J.A., Mulder, P.G., Pepplinkhuizen, L., Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Res. 103:2-3 (2001), 115–123.
61. Janelidze, S., Mattei, D., Westrin, A., Traskman-Bendz, L., Brundin, L., Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav. Immun. 25:2 (2011), 335–339.
62. Jochum, S., Moosmann, A., Lang, S., Hammerschmidt, W., Zeidler, R., The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog., 8(5), 2012, e1002704.
63. Jonah, B.A., Thiessen, R., Au-Yeung, E., Sensation seeking, risky driving and behavioral adaptation. Accid. Anal. Prev. 33:5 (2001), 679–684.
64. Kaufman, S., The phenylalanine hydroxylating system from mammalian liver. Adv. Enzymol. Relat. Areas Mol. Biol. 35 (1971), 245–319.
65. Kayser, A.S., Allen, D.C., Navarro-Cebrian, A., Mitchell, J.M., Fields, H.L., Dopamine, corticostriatal connectivity, and intertemporal choice. J. Neurosci. 32:27 (2012), 9402–9409.
66. Kocazeybek, B., Oner, Y.A., Turksoy, R., Babur, C., Cakan, H., Sahip, N., et al. Higher prevalence of toxoplasmosis in victims of traffic accidents suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of Istanbul and its suburbs. Forensic Sci. Int. 187:1–3 (2009), 103–108.
67. Kovacsics, C.E., Gottesman, I.I., Gould, T.D., Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu. Rev. Pharmacol. Toxicol. 49 (2009), 175–198.
68. Kruesi, M.J., Rapoport, J.L., Hamburger, S., Hibbs, E., Potter, W.Z., Lenane, M., et al. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch. Gen. Psychiatry 47:5 (1990), 419–426.
69. Kubera, M., Kenis, G., Bosmans, E., Zieba, A., Dudek, D., Nowak, G., et al. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol. J. Pharmacol. 52:3 (2000), 237–241.
70. Laget, J., Plancherel, B., Stephan, P., Bolognini, M., Corcos, M., Jeammet, P., et al. Personality and repeated suicide attempts in dependent adolescents and young adults. Crisis 27:4 (2006), 164–171.
71. Linderholm, K.R., Alm, M.T., Larsson, M.K., Olsson, S.K., Goiny, M., Hajos, M., et al. Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons. Neuropharmacology 102 (2016), 42–47.
72. Lindova, J., Kubena, A.A., Sturcova, H., Krivohlava, R., Novotna, M., Rubesova, A., et al. Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol. (Praha) 57:2 (2010), 136–142.
73. Lindova, J., Novotna, M., Havlicek, J., Jozifkova, E., Skallova, A., Kolbekova, P., et al. Gender differences in behavioural changes induced by latent toxoplasmosis. Int. J. Parasitol. 36:14 (2006), 1485–1492.
74. Ling, V.J., Lester, D., Mortensen, P.B., Langenberg, P.W., Postolache, T.T., Toxoplasma gondii seropositivity and suicide rates in women. J. Nerv. Ment. Dis. 199:7 (2011), 440–444.
75. Luijten, M., Veltman, D.J., Hester, R., Smits, M., Nijs, I.M., Pepplinkhuizen, L., et al. The role of dopamine in inhibitory control in smokers and non-smokers: a pharmacological fMRI study. Eur. Neuropsychopharmacol. 23:10 (2013), 1247–1256.
76. Lund-Sorensen, H., Benros, M.E., Madsen, T., Sorensen, H.J., Eaton, W.W., Postolache, T.T., et al. A Nationwide cohort study of the association between hospitalization with infection and risk of death by suicide. JAMA Psychiatry 73:9 (2016), 912–919.
77. Malloy-Diniz, L.F., Lage, G.M., Campos, S.B., de Paula, J.J., de Souza Costa, D., Romano-Silva, M.A., et al. Association between the Catechol O-methyltransferase (COMT) Val158met polymorphism and different dimensions of impulsivity. PLoS One, 8(9), 2013, e73509.
78. Mann, J.J., Arango, V.A., Avenevoli, S., Brent, D.A., Champagne, F.A., Clayton, P., et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol. Psychiatry 65:7 (2009), 556–563.
79. Martin, H.L., Alsaady, I., Howell, G., Prandovszky, E., Peers, C., Robinson, P., et al. Effect of parasitic infection on dopamine biosynthesis in dopaminergic cells. Neuroscience 306 (2015), 50–62.
80. Massa, N.M., Duncan, E., Jovanovic, T., Kerley, K., Weng, L., Gensler, L., et al. Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an inner-city population. Brain Behav. Immun. 61 (2017), 176–183.
81. Mathai, A.J., Lowry, C.A., Cook, T.B., Brenner, L.A., Brundin, L., Groer, M.W., et al. Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine–tyrosine ratio of their associations with trait aggression. Pteridines 27:3-4 (2016), 77–85.
82. Matuskey, D., Luo, X., Zhang, S., Morgan, P.T., Abdelghany, O., Malison, R.T., et al. Methylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individuals. Psychiatry Res. 214:2 (2013), 116–121.
83. McConkey, G.A., Martin, H.L., Bristow, G.C., Webster, J.P., Toxoplasma gondii infection and behaviour - location, location, location?. J Exp. Biol. 216:Pt 1 (2013), 113–119.
84. McNally, L., Bhagwagar, Z., Hannestad, J., Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 13:6 (2008), 501–510.
85. Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65:9 (2009), 732–741.
86. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16:1 (2016), 22–34.
87. Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., Kirkpatrick, B., Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70:7 (2011), 663–671.
88. Mitchell, M.R., Potenza, M.N., Recent insights into the neurobiology of impulsivity. Curr. Addict. Rep. 1:4 (2014), 309–319.
89. Moeller, F.G., Barratt, E.S., Dougherty, D.M., Schmitz, J.M., Swann, A.C., Psychiatric aspects of impulsivity. Am. J. Psychiatry 158:11 (2001), 1783–1793.
90. Nagineni, C.N., Pardhasaradhi, K., Martins, M.C., Detrick, B., Hooks, J.J., Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64:10 (1996), 4188–4196.
91. Najjar, S., Pearlman, D.M., Alper, K., Najjar, A., Devinsky, O., Neuroinflammation and psychiatric illness. J. Neuroinflammation, 10, 2013, 43.
92. Nandam, L.S., Hester, R., Wagner, J., Dean, A.J., Messer, C., Honeysett, A., et al. Dopamine D(2) receptor modulation of human response inhibition and error awareness. J. Cogn. Neurosci. 25:4 (2013), 649–656.
93. Neurauter, G., Grahmann, A.V., Klieber, M., Zeimet, A., Ledochowski, M., Sperner-Unterweger, B., et al. Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Lett. 272:1 (2008), 141–147.
94. Neurauter, G., Scholl-Burgi, S., Haara, A., Geisler, S., Mayersbach, P., Schennach, H., et al. Simultaneous measurement of phenylalanine and tyrosine by high performance liquid chromatography (HPLC) with fluorescence detection. Clin. Biochem. 46:18 (2013), 1848–1851.
95. Neurauter, G., Schrocksnadel, K., Scholl-Burgi, S., Sperner-Unterweger, B., Schubert, C., Ledochowski, M., et al. Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr. Drug Metab. 9:7 (2008), 622–627.
96. Nicholas, J., Human gammaherpesvirus cytokines and chemokine receptors. J. Interferon Cytokine Res. 25:7 (2005), 373–383.
97. Okuno, A., Fukuwatari, T., Shibata, K., High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum. J. Neurochem. 118:5 (2011), 796–805.
98. Okusaga, O., Duncan, E., Langenberg, P., Brundin, L., Fuchs, D., Groer, M.W., et al. Combined Toxoplasma gondii seropositivity and high blood kynurenine–linked with nonfatal suicidal self-directed violence in patients with schizophrenia. J. Psychiatr. Res. 72 (2016), 74–81.
99. Okusaga, O., Langenberg, P., Sleemi, A., Vaswani, D., Giegling, I., Hartmann, A.M., et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr. Res. 133:1–3 (2011), 150–155.
100. Okusaga, O., Muravitskaja, O., Fuchs, D., Ashraf, A., Hinman, S., Giegling, I., et al. Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?. PLoS One, 9(1), 2014, e85945.
101. Oquendo, M.A., Galfalvy, H., Russo, S., Ellis, S.P., Grunebaum, M.F., Burke, A., et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am. J. Psychiatry 161:8 (2004), 1433–1441.
102. Oswald, L.M., Wong, D.F., Zhou, Y., Kumar, A., Brasic, J., Alexander, M., et al. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 36:1 (2007), 153–166.
103. Paaver, M., Nordquist, N., Parik, J., Harro, M., Oreland, L., Harro, J., Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology (Berl) 194:4 (2007), 545–554.
104. Pappas, G., Roussos, N., Falagas, M.E., Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 39:12 (2009), 1385–1394.
105. Parlog, A., Schluter, D., Dunay, I.R., Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 37:3 (2015), 159–170.
106. Patel, A., Siegel, A., Zalcman, S.S., Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav. Immun. 24:8 (2010), 1276–1280.
107. Pearce, B.D., Kruszon-Moran, D., Jones, J.L., The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol. Psychiatry 72:4 (2012), 290–295.
108. Pedersen, M.G., Mortensen, P.B., Norgaard-Pedersen, B., Postolache, T.T., Toxoplasma gondii infection and self-directed violence in mothers. Arch. Gen. Psychiatry 69:11 (2012), 1123–1130.
109. Perry, J.L., Carroll, M.E., The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 200:1 (2008), 1–26.
110. Pesce, M., Speranza, L., Franceschelli, S., Ialenti, V., Patruno, A., Febo, M.A., et al. Biological role of interleukin-1beta in defensive-aggressive behaviour. J. Biol. Regul. Homeost. Agents 25:3 (2011), 323–329.
111. Pezze, M.A., Dalley, J.W., Robbins, T.W., Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride. Psychopharmacology (Berl) 202:1-3 (2009), 307–313.
112. Pfefferkorn, E.R., Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81:3 (1984), 908–912.
113. Ploder, M., Neurauter, G., Spittler, A., Schroecksnadel, K., Roth, E., Fuchs, D., Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 35:2 (2008), 303–307.
114. Pompili, M., Serafini, G., Innamorati, M., Dominici, G., Ferracuti, S., Kotzalidis, G.D., et al. Suicidal behavior and alcohol abuse. Int. J. Environ. Res. Public Health 7:4 (2010), 1392–1431.
115. Postolache, T.T., Cook, T.B., Is latent infection with Toxoplasma gondii a risk factor for suicidal behavior?. Expert Rev. Anti Infect. Ther. 11:4 (2013), 339–342.
116. Potvin, S., Stip, E., Sepehry, A.A., Gendron, A., Bah, R., Kouassi, E., Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 63:8 (2008), 801–808.
117. Prandovszky, E., Gaskell, E., Martin, H., Dubey, J.P., Webster, J.P., McConkey, G.A., The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One, 6(9), 2011, e23866.
118. Rao, M.L., Gross, G., Strebel, B., Braunig, P., Huber, G., Klosterkotter, J., Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res. 34:3 (1990), 243–257.
119. Retz, W., Rosler, M., Supprian, T., Retz-Junginger, P., Thome, J., Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J. Neural Transm. (Vienna) 110:5 (2003), 561–572.
120. Roberti, J.W., A review of behavioral and biological correlates of sensation seeking. J. Res. Pers. 38:3 (2004), 256–279.
121. Roberti, J.W., Storch, E.A., Bravata, E., Further psychometric support for the sensation seeking scale–form V. J. Pers. Assess. 81:3 (2003), 291–292.
122. Saklayen, S.S., Mabrouk, O.S., Pehek, E.A., Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. J. Pharmacol. Exp. Ther. 311:1 (2004), 342–348.
123. Samojlowicz, D., Borowska-Solonynko, A., Golab, E., Prevalence of Toxoplasma gondii parasite infection among people who died due to sudden death in the capital city of Warsaw and its vicinity. Prz. Epidemiol., 67(1), 2013 29-33, 115-118.
124. Sharma, L., Markon, K.E., Clark, L.A., Toward a theory of distinct types of “impulsive” behaviors: A meta-analysis of self-report and behavioral measures. Psychol. Bull/ 140:2 (2014), 374–408.
125. Silva, N.M., Rodrigues, C.V., Santoro, M.M., Reis, L.F., Alvarez-Leite, J.I., Gazzinelli, R.T., Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect. Immun. 70:2 (2002), 859–868.
126. Simon, N.W., Beas, B.S., Montgomery, K.S., Haberman, R.P., Bizon, J.L., Setlow, B., Prefrontal cortical-striatal dopamine receptor mRNA expression predicts distinct forms of impulsivity. Eur. J. Neurosci. 37:11 (2013), 1779–1788.
127. Skallova, A., Kodym, P., Frynta, D., Flegr, J., The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 133:Pt 5 (2006), 525–535.
128. Soyka, M., Neurobiology of aggression and violence in schizophrenia. Schizophr. Bull. 37:5 (2011), 913–920.
129. Spellberg, B., Edwards, J.E. Jr., Type 1/Type 2 immunity in infectious diseases. Clin. Infect. Dis. 32:1 (2001), 76–102.
130. Stibbs, H.H., Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann. Trop. Med. Parasitol. 79:2 (1985), 153–157.
131. Suarez, E.C., Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom. Med. 65:4 (2003), 523–527.
132. Suarez, E.C., Lewis, J.G., Krishnan, R.R., Young, K.H., Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 29:9 (2004), 1119–1128.
133. Sugden, K., Moffitt, T.E., Pinto, L., Poulton, R., Williams, B.S., Caspi, A., Is Toxoplasma gondii infection related to brain and behavior impairments in humans? evidence from a population-representative birth cohort. PLoS One, 11(2), 2016, e0148435.
134. Sutterland, A.L., Fond, G., Kuin, A., Koeter, M.W., Lutter, R., van Gool, T., et al. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr. Scand. 132:3 (2015), 161–179.
135. Swann, A.C., Lijffijt, M., Lane, S.D., Steinberg, J.L., Moeller, F.G., Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord. 11:3 (2009), 280–288.
136. Swerdlow, N.R., Braff, D.L., Geyer, M.A., Koob, G.F., Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatry 21:1 (1986), 23–33.
137. Tan, D., Soh, L.J., Lim, L.W., Daniel, T.C., Zhang, X., Vyas, A., Infection of male rats with Toxoplasma gondii results in enhanced delay aversion and neural changes in the nucleus accumbens core. Proc. Biol. Sci., 282(1808), 2015, 20150042.
138. Tan, D., Vyas, A., Toxoplasma gondii infection and testosterone congruently increase tolerance of male rats for risk of reward forfeiture. Horm. Behav. 79 (2016), 37–44.
139. Tedla, Y., Shibre, T., Ali, O., Tadele, G., Woldeamanuel, Y., Asrat, D., et al. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop. Med. J. 49:3 (2011), 211–220.
140. Torrey, E.F., Bartko, J.J., Yolken, R.H., Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 38:3 (2012), 642–647.
141. Trimpop, R.M., Kerr, J.H., Kirkcaldy, B., Comparing personality constructs of risk-taking behavior. Pers. Individ. Dif. 26:2 (1998), 237–254.
142. Turecki, G., Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J. Psychiatry Neurosci. 30:6 (2005), 398–408.
143. van Gaalen, M.M., Brueggeman, R.J., Bronius, P.F., Schoffelmeer, A.N., Vanderschuren, L.J., Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 187:1 (2006), 73–85.
144. van Spronsen, F.J., Hoeksma, M., Reijngoud, D.J., Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?. J. Inherit. Metab. Dis. 32:1 (2009), 46–51.
145. Volavka, J., Citrome, L., Pathways to aggression in schizophrenia affect results of treatment. Schizophr. Bull. 37:5 (2011), 921–929.
146. Voon, V., Reynolds, B., Brezing, C., Gallea, C., Skaljic, M., Ekanayake, V., et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 207:4 (2010), 645–659.
147. Webster, J.P., Lamberton, P.H., Donnelly, C.A., Torrey, E.F., Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc. Biol. Sci. 273:1589 (2006), 1023–1030.
148. Wei, J., Xu, H., Ramchand, C.N., Hemmings, G.P., Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset. Schizophr. Res. 14:3 (1995), 257–260.
149. Werner, E.R., Blau, N., Thony, B., Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem. J. 438:3 (2011), 397–414.
150. Wilson, L.C., Scarpa, A., Baseline heart rate, sensation seeking, and aggression in young adult women: a two-sample examination. Aggress. Behav. 39:4 (2013), 280–289.
151. Wu, H.Q., Rassoulpour, A., Schwarcz, R., Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?. J. Neural Transm. (Vienna) 114:1 (2007), 33–41.
152. Wurtman, R.J., Rose, C.M., Chou, C., Larin, F.F., Daily rhythms in the concentrations of various amino acids in human plasma. N. Engl. J. Med. 279:4 (1968), 171–175.
153. Xiao, J., Li, Y., Prandovszky, E., Karuppagounder, S.S., Talbot, C.C. Jr., Dawson, V.L., et al. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 268 (2014), 128–138.
154. Xu, S., Das, G., Hueske, E., Tonegawa, S., Dorsal raphe serotonergic neurons control intertemporal choice under trade-off. Curr. Biol. 27:20 (2017), 3111–3119 e3113.
155. Yagmur, F., Yazar, S., Temel, H.O., Cavusoglu, M., May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects?. Forensic Sci. Int. 199:1–3 (2010), 15–17.
156. Yereli, K., Balcioglu, I.C., Ozbilgin, A., Is Toxoplasma gondii a potential risk for traffic accidents in Turkey?. Forensic Sci. Int. 163:1-2 (2006), 34–37.
157. Zalcman, S.S., Siegel, A., The neurobiology of aggression and rage: role of cytokines. Brain Behav. Immun. 20:6 (2006), 507–514.
158. Zangerle, R., Kurz, K., Neurauter, G., Kitchen, M., Sarcletti, M., Fuchs, D., Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy. Brain Behav. Immun. 24:3 (2010), 403–408.
159. Zhang, Y., Traskman-Bendz, L., Janelidze, S., Langenberg, P., Saleh, A., Constantine, N., et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J. Clin. Psychiatry 73:8 (2012), 1069–1076.
160. Zuckerman, M., Behavioral Expressions and Biosocial Bases of Sensation Seeking. 1994, Cambridge Univ. Press, Cambridge, UK.
161. Zuckerman, M., Neeb, M., Sensation seeking and psychopathology. Psychiatry Res. 1:3 (1979), 255–264.